US 6,918,924 B2Grant

Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid

Issue Date:2005-07-19

•16 Claims

•11 Drawing Sheets

Abstract

A method and apparatus is provided for heating or cooling at least a selected portion of a patient's body. The method begins by inserting a catheter through the urethra and into the bladder of the patient. A heated or chilled fluid is conducted through a supply lumen of the catheter and into the bladder. The fluid is evacuated from the bladder through a return lumen of the catheter. Finally, a quantity of urine is monitored which flows out of the bladder and through the return lumen of the catheter. The rate of fluid flowing through the supply lumen of the catheter may be adjusted in a manner that is based at least in part on the monitored quantity of urine flowing out of the bladder.

Metadata

Assignee

Innercool Therapies, Inc.

Inventors

Juan C. Lasheras
Steven A. Yon
Michael Magers

Application Information

Application Number:US 10/716,205

Filing Date:2003-11-17

Priority Date:2000-04-06

Art Unit:3739

Patent Drawings (11 sheets)

Description

Related Applications

[0001] This application is a continuation of U.S. patent application Ser. No. 09/827,010, filed on Apr. 5, 2001 now U.S. Pat. No. 6,648,906, entitled “Method And Apparatus For Regulating Patient Temperature By Irrigating The Bladder With A Fluid” which is a continuation-in-part of U.S. patent application Ser. No. 09/586,000, filed on Jun. 2, 2000 now U.S. Pat. No. 6,383,210, entitled “Method For Determining The Effective Thermal Mass Of A Body Or Organ Using A Cooling Catheter,” and claims priority to U.S. Provisional Patent Application Ser. No. 60/195,609, filed Apr. 6, 2000, entitled “Bladder Cooling for Total Body Therapeutic Hypothermia”, and U.S. Provisional Patent Application Ser. No. 60/270,525, filed Feb. 21, 2001, entitled “Method And Apparatus For Regulating Patient Temperature By Irrigating The Bladder With A Fluid”, all of which are incorporated herein by reference.

Background of the Invention

[0002] I. Field of the Invention

[0003] The present invention relates generally to the modification and control of the temperature of the body. More particularly, the invention relates to a method for controlling body temperature by irrigating the bladder with a working fluid.

[0004] II. Description of the Related Art

[0005] Organs in the human body, such as the brain, kidney and heart, are maintained at a constant temperature of approximately 37° C. Hypothermia can be clinically defined as a core body temperature of 35° C. or less. Hypothermia is sometimes characterized further according to its severity. A body core temperature in the range of 33° C. to 35° C. is described as mild hypothermia. A body temperature of 28° C. to 32° C. is described as moderate hypothermia. A body core temperature in the range of 24° C. to 28° C. is described as severe hypothermia.

[0006] Patients may require pre or post-operative cooling for a variety of reasons, including, for example, treatment of a malignant hypothermia crisis and induction of therapeutic hypothermia for neurosurgery.

[0007] Catheters have been developed which are inserted into the bloodstream of the patient in order to induce total body hypothermia. For example, U.S. Pat. No. 3,425,419 to Dato describes a method and apparatus of lowering and raising the temperature of the human body. The Dato invention is directed towards a method of inducing moderate hypothermia in a patient using a metallic catheter. The metallic catheter has an inner passageway through which a fluid, such as water, can be circulated. The catheter is inserted through the femoral vein and then through the inferior vena cava as far as the right atrium and the superior vena cava. The Dato catheter has an elongated cylindrical shape and is constructed from stainless steel.

[0008] Other less cumbersome catheters have been developed to provide cooling intravascularly. For example, a heat transfer element such as disclosed in U.S. Pat. No. 6,096,068, incorporated herein by reference in its entirety, may be placed in the feeding artery of an organ to absorb or deliver the heat from or to the blood flowing into the organ. The transfer of heat may cause either a cooling or a heating of the selected organ. The heat transfer element is small enough to fit within the feeding artery while still allowing a sufficient blood flow to reach the organ in order to avoid ischemic organ damage. By placing the heat transfer element within the feeding artery of an organ, the temperature of the organ can be controlled with less of an effect on the temperature of the remaining parts of the body. A similar heat transfer device, which is employed for whole body cooling and is disposed in the venous vasculature, is disclosed in U.S. application Ser. No. 09/373,112, also incorporated by reference in its entirety.

[0009] While the previously mentioned techniques provide significant thermal control, they require the insertion of a catheter into the vascular system to induce heat transfer between the catheter and the blood stream. This is a relatively invasive procedure, which has an associated level of risk.

[0010] Accordingly, it would be desirable to provide an effective, less invasive method and apparatus for heating or cooling all or part of a patient's body. It would also be desirable to provide an effective, less invasive method and apparatus for heating or cooling all or part of a patient's body that could be employed in emergency situations, such as on an ambulance.

Summary of the Invention

[0011] The present invention provides a method and apparatus for heating or cooling at least a selected portion of a patient's body. The method begins by inserting a catheter through the urethra and into the bladder of the patient. A heated or chilled fluid is conducted through a supply lumen of the catheter and into the bladder. The fluid is evacuated from the bladder through a return lumen of the catheter. Finally, a quantity of urine is monitored which flows out of the bladder and through the return lumen of the catheter.

[0012] In accordance with one aspect of the invention, the rate of fluid flowing through the supply lumen of the catheter is adjusted in a manner that is based at least in part on the monitored quantity of urine flowing out of the bladder.

[0013] In accordance with another aspect of the invention, the fluid is conducted into the supply lumen at a substantially constant flow rate, or alternatively, at a periodically interrupted rate. In one particular embodiment of the invention, the flow rate is less than a flow rate that would substantially prevent fluid from flowing from the kidneys to the bladder. In this or another embodiment of the invention, the flow rate of fluid conducted into the supply lumen is substantially equal to a flow rate of fluid being evacuated from the bladder.

[0014] In accordance with another aspect of the invention, the pressure of the fluid flowing into the supply lumen is monitored. The pressure of the fluid flowing through the return lumen may be monitored as well.

[0015] In accordance with yet another aspect of the invention, a temperature differential is monitored between the fluid conducted into the supply lumen and the fluid flowing through the return lumen.

Brief Description of the Drawings

[0016] FIG. 1 is a partially perspective and partially schematic view of a catheter system including a circulation set constructed in accordance with the present invention.

[0017] FIG. 2 is a schematic illustration of the circulation set depicted in FIG. 1, showing in particular the flow of the working fluid.

[0018] FIG. 3 shows the distal end of the catheter depicted in FIGS. 1 and 2 inserted into the bladder.

[0019] FIGS. 4-8 show different arrangements of the distal end of the catheter depicted in FIGS. 1 and 2 inserted into the bladder.

[0020] FIG. 9 shows a cross-section of the catheter at a point proximal of the balloon.

[0021] FIGS. 10-12 show various optional dispersion tips located on the supply orifice of the catheter for distributing fluid throughout the bladder.

[0022] FIG. 13 shows a cross-section of the dispersion tip of FIG. 12.

[0023] FIG. 14A shows a prior art heat exchange system.

[0024] FIG. 14B shows a heat exchange system constructed in accordance with an embodiment of the invention.

Detailed Description of the Invention

[0025] The present invention provides a relatively non-intrusive method and apparatus for heating or cooling all or part of a patient's body. The invention achieves this result by circulating a heat transfer fluid through the patient's bladder 11 (see FIG. 3). Heat transfer via the bladder 11 is advantageous because the bladder 11 is located in the abdominal cavity, surrounded by a variety of organs, and in addition the bladder walls are highly perfused with blood. Further, the abdominal cavity volume includes a substantial portion of the high blood flow vessels the aorta 17 and the inferior vena cava 19. The fluid absorbs heat from or delivers heat through the wall of the bladder 11 and into the abdominal cavity and the arterial and venous vessels populating this area, thereby regulating the temperature of a patient's whole body or one or more selected organs. In particular, the bladder 11 is supplied with blood by the superior, middle and inferior vesical arteries, which arise from the auterior trunk of the intereal iliac artery. As a result, cooling of the internal organs and a considerable amount of blood can be accomplished without the invasive step of inserting a catheter directly into the vascular system.

[0026] In addition, for surgeries requiring more than about two hours to perform, insertion of a catheter into the bladder to monitor urine output is a common procedure. Such urethral catheters are commonly termed “Foley” catheters. A common Foley-type catheter may be the basis for the design and construction of a catheter according to the invention. As described below, however, significant modifications may be made to a common Foley catheter in order to make the same optimum for the present methods.

[0027] FIG. 1 shows one embodiment of the bladder thermal control system 20 constructed in accordance with the present invention. The system includes a catheter 100, control system 26, and a circulation set 28 partially housed by the control unit system 26. The control system 26 may be equipped with an output display 36 and input keys 40 to facilitate user interaction with the control system 26. While FIG. 1 shows a fairly large and relatively complex control system 26, the complexity of the same depends on the application to which the same is put. For example, for a rewarming application, the control system 26 may be a simple Mallinkrodt Blood and Fluid Warmer, as manufactured by Mallinkrodt Medical of St. Louis, Mo.

[0028] Alternatively, for certain applications, such as rewarming or maintaining normothermia during a surgery or other procedure, the nature of the heat exchanger used within the control system may be simple, such as a simple resistive heat exchanger or thermo-electric heat exchanger.

[0029] The catheter 100, which may employ a design similar to that of a Foley catheter, for example, is configured for insertion into the urethra. The proximal end of the catheter 100 includes a manifold 105 having an inlet port 102 and an outlet port 104 on its proximal end. A supply lumen 106 and a return lumen 108 are connected to a port located on the distal end of the manifold 105. At the catheter's distal end the supply and return lumens 106 and 108 respectively terminate in supply and return orifices 110 and 112. The catheter may have a diameter of, e.g., 18 F or another size as dictated by the requirements of the user.

[0030] The supply orifice 110 may include an optional dispersion tip. In FIG. 3, both a supply orifice 115 and a dispersion tip 116 are shown, although in practice typically only one or the other would be used. The supply orifice 110 may cause the fluid to emerge in a direction parallel to the axis of the catheter (supply orifice 110) or perpendicular to the same (supply orifice 115). These aspects are discussed in more detail below in connection with FIGS. 4-8.

[0031] Whether a dispersion tip is used or not, the distal tip or supply orifice of the catheter may be made of a very soft material so as to minimize tissue damage of the urethra upon insertion. The same may be coated with various materials to minimize deleterious coating of undesired biological materials on the tip during or after insertion.

[0032] The supply and return lumens 106 and 108 may be formed from a pair of concentric flexible tubes so that the supply lumen 106 may be concentrically located within the annular return lumen 108. Of course, the same may also be non-coaxial as dictated by the requirements of the user. As shown in more detail in FIG. 3, when the catheter 100 is properly inserted into the urethra its distal end is located in the bladder. Fluid is conducted into the bladder from the supply lumen 106 via supply orifice 110. Fluid is conducted out of the bladder 11 via at least one return orifice 112 and into return lumen or lumens 108. As FIG. 3 indicates, in some embodiments of the invention the supply orifice 110 is spatially separated from the return orifices 112 so that fluid has an opportunity to thoroughly irrigate the bladder 11 before returning through the return orifice 112.

[0033] As in a conventional Foley catheter, the catheter 100 may include a balloon 14 (see FIGS. 3 and 4) near its tip to prevent its expulsion from the urethra. The balloon 14 may also serve the purpose of anchoring the catheter against movement caused by a pulsating working fluid supply, as may be the case if certain types of pumps are employed to drive the working fluid. The balloon 14 may be inflated by a single inflation lumen, a dual inflation lumen, or other such lumen as is known.

[0034] Referring to FIG. 9, one embodiment of a catheter shaft is shown in cross-section. The catheter shaft 123 includes a supply lumen 106 and a return lumen 108. A lumen 122 is also shown for providing a space through which to deliver cabling to pressure monitor 77; however, cabling for pressure monitor 77 may also be provided through a microcatheter or capillary catheter disposed within the supply lumen 106 or the return lumen 108. A separate lumen 125 is also shown for use in inflating and deflating balloon 114. A separate lumen 125 is also shown for use in delivering various drugs. While four separate lumens are shown in FIG. 9, more or less may be provided depending on the requirements of the user. With reference to FIGS. 1 and 2, an embodiment of the circulation set 28 will now be described. The circulation set 28 may include one or more of the following: a fluid reservoir 60, a pump 64, a filter 68, a heat exchanger 72, a temperature and pressure sensor assembly 76, supply line 80, and a return line 84. The supply line 80 and return line 84 are preferably comprised of one or more pieces of tubing, connectors, etc. joining the aforementioned components of the circulation set 28. The circulation set 28 supplies, filters, circulates, and monitors the temperature and pressure of the heat transfer fluid for the catheter 24.

[0035] In one embodiment, the fluid reservoir 60 is a modified IV bag made of PVC filled with saline. Since the typical bladder volume is about 500-750 cc, the volume of the fluid reservoir 60 should be greater than about 1000 cc. In this way the entire working fluid, as well as urine produced during the procedure, can be contained within the reservoir 60. Other working fluids besides saline such as, but not limited to, isotonic solutions, Ringer solution, and the like may be used. Various other solutions may be employed, including those that act to neutralize the proteins inherent in urine. In this way, when the combination of working fluid and urine is recirculated back into the bladder, the danger of infection is minimized.

[0036] The fluid reservoir 60 is used to prime the lines 80, 84 and lumens 106 and 108 of the catheter 100. For example, the system may be primed with 0.9% saline, and then the pump speed adjusted such that the driving pressure of the working fluid (by the pump) plus the return vacuum cancel out. Then, if a higher flow rate is desired, the collection bag, reservoir 60, may simply be raised higher. The fluid reservoir 60 includes a supply or inlet tube 90 that communicates at an inlet 91 with the return line 84 outside of the reservoir 60 and communicates at an opposite end or outlet 92 with an inside 94 of the reservoir 60. The fluid reservoir 60 also includes a return or outlet tube 96 that communicates at one end with the supply line 80 outside of the reservoir 60 and communicates at an opposite end, i.e., at an inlet 98, with the inside 94 of the reservoir 60.

[0037] The reservoir 60 may typically have a pressure of about 75 mm Hg (1.4 psi), although the same may be pressurized to achieve higher pressures, e.g., 300 mm Hg (5.6 psi).

[0038] The filter 68 is preferably a 5-micron filter carried by male and female housing members. The filter 68 removes impurities from the circulating heat transfer fluid. In other embodiments of the circulation set 28, the circulation set 28 may include more than one filter 68, the circulation set 28 may include no filters 68, or the filter 68 may be a part of one or more components of the circulation set.

[0039] The heat exchanger 72, which is used to heat or chill the fluid supplied to the catheter, may be any of a variety of conventionally designed heat exchangers. As noted above, the heat exchanger 72 may employ a resistive heater, a microwave heater, a thermoelectric device, a closed-circuit temperature control system, etc.

[0040] In another embodiment, a height differential ‘h’ may be employed between an additional fluid reservoir, such as an elevated IV bag, and the catheter. The purpose of the pump would then be to pump the combination working fluid and urine up to the additional fluid reservoir. This has a benefit in that many physicians, such as urologists, are more comfortable reading bladder pressure as centimeters of water. For example, many urologists use, as a rule of thumb, about 10-20 centimeters of water as a safe bladder pressure. The height of the top of the water in the IV bag, referenced to the approximate height of the bladder, can then be easily visually used as a measure of bladder inflation pressure.

[0041] One difficulty with this technique may be that, to force a sufficient quantity of working fluid through a catheter of reasonable size entails placing the IV bag at a height much higher than 10-20 centimeters, limiting the locations where the technique can be employed.

[0042] The control of the speed of pump 64 may be primarily given to control circuit 126, and a primary determinant of the pump speed may be the core body temperature as determined by a temperature monitor 128. The temperature monitor 128 may be an esophageal monitor, a tympanic monitor, or any other type of temperature monitor as is known in the art with which core body temperature may be monitored. In other words, the measured patient temperature may be the primary parameter on which depends the speed of pump 64. The value of the internal bladder pressure may also be used as a safety control to ensure that a dangerous over-pressure situation never arises, as is described in more detail below.

[0043] More specifically, if ΔT=Target Temperature−Core Temperature, then ΔT and the internal bladder pressure may determine the pump speed and the level of “valving” of a pinch valve 65. For example, a “span” may be defined which corresponds to a ΔT small enough that very close control by control circuit 26 must occur in order to prevent overshoot. If ΔT>the span, i.e., the target temperature is relatively far from the core temperature, then the pump speed is maximized and the pinch valve 65 actuated to maintain the pressure of working fluid in the bladder 11. In this mode, the maximum amount of heating (or cooling) would occur. The pinch valve 65 is actuated to ensure that the bladder is not over-pressurized, as may be measured directly or inferred by a technique described below. If ΔT is between zero and the span, then the pump speed may be set proportional to ΔT, and/or the pinch valve 65 may be regulated to maintain the pressure of the working fluid in the bladder 11. In fact, due to a lessened pump speed, the pinch valve 65 may require significant opening in order to maintain the pressure of the working fluid in the bladder 11. This is because it has been noted that the pressure of the working fluid in the bladder must be maintained in order to maintain a satisfactory heat transfer rate.

[0044] As noted above, a pressure sensor 77 may be employed to measure the pressure of the working fluid in the bladder 11. This pressure sensor 77 may be provided through a throughlumen in either the supply/inlet lumen or the return/outlet lumen, and may comprise a standard medical-grade pressure transducer. This pressure sensor 77 may be referenced to a core pressure monitor 127 (the transducer of which is not shown in FIG. 2) and both may provide signals to the control circuit 126. In particular, the measured bladder pressure may be employed, when ΔT is less than the span, to control the level of valving of pinch valve 65 in order to maintain the bladder pressure at as high a level as is safe and effective for heat transfer to occur. A typical operating pressure for safe use in the bladder has been quoted in some sources as being in the range of 0.2 to 0.3 psi. It is also noted that a typical ureter transport pressure, i.e., the maximum bladder pressure which would allow an influx of urine from the ureters, has been suggested to be about 20-60 cm H₂0 or about 0.28-0.85 psi. Thus, this value, if properly assessed and measured, may also be used as a maximum pressure. For example, a conservative approach may be to use the lesser of the allowed pressures as a maximum.

[0045] The pressure sensor 77 and the control circuit 126 may be designed such that if a pressure higher than a predetermined value is encountered in the bladder, the pump 64 shuts down or the valve 65 completely closes or both. Other failsafe procedures may also be employed.

[0046] The pressure sensor 77 may be referenced to an internal pressure measured at another location, such as the heart line, etc. In abdominal surgery, such a reference pressure may be neglected.

[0047] As shown in FIGS. 4-8, the pressure sensor 77 may be located in various locations with respect to the supply orifice 110. In FIG. 4, the pressure sensor 77 and the supply orifice 110 are shown in roughly the same location at the distal tip of the catheter. The pressure sensor 77 may also be proximal of the distal tip, as shown in FIG. 5. The same could be true in the case where a side supply orifice 115 is employed (FIG. 6). Alternatively, where a side supply orifice 115 is employed, the pressure sensor 77 may be located at the distal tip of the catheter (FIG. 7). If a dispersion tip 116 is employed, as is shown schematically in FIG. 8, the pressure sensor 77 may be located at the distal tip of the catheter or proximal of the distal tip of the catheter.

[0048] As noted above, the pump 64 is provided to draw the heat transfer fluid from the fluid reservoir 60 and push the fluid into the bladder 11. The flow rate of the heat transfer fluid is then determined by the speed of pump 64 as well as the state of valve 65. If the fluid column is continuous from the return ports (in the bladder) to the reservoir 60, a height h below the bladder, an effective pressure of
p=ρgh−Ku²

[0049] where K is the head loss coefficient of the drain path. In practice, maintaining a complete fluid column in the drain path results in effective draining of the bladder. To control the amount of draining, a valve 65′ may be disposed in the drain path. Valve 65′ may be used either in combination with valve 65 or in place thereof.

[0050] In this system, a specified flux of working fluid may be supplied to the bladder. Valve 65′ can be actuated to obtained the desired bladder pressure and volume. If the supply flux is less than the drain flux, when the valve 65′ is completely open, then for p_bladder<p_maximum, the system will not overpressure the bladder.

[0051] The temperature and pressure sensor assembly 76 is used in one embodiment for measuring the temperature and the pressure of the heat transfer fluid in the supply line 80 before it enters the catheter 24, and measuring the temperature and the pressure of the heat transfer fluid in the return line 84, after it leaves the catheter 24. As described in more detail below, one or both of these measurements are important for determining not only the heating or cooling efficiency that can be achieved with the catheter 100, but also to ensure that the patient's bladder 11 is not irrigated at such a high rate, or subjected to such a high pressure, that renal failure occurs. The temperature and pressure sensor assembly 76 includes thermocouples and pressure transducers for respectively measuring the temperature and pressure of the fluid, and may also include associated electronics.

[0052] Signals from the temperature and pressure assembly 76 are provided to control the control circuit 126 within control unit 26 (FIGS. 1 and 2). As noted above, this information is used by control unit 26 as feedback to control the throughput of pump 64 (if included in circulation set 28), which in turn determines the flow rate of the fluid based on input parameters supplied to the control unit 26 via user input keys 40. The control unit 26 may also determine the rate of heat transferred to and from the working fluid by the heat exchanger 72.

[0053] The temperature and pressure sensor assembly 76 may include alarms that shut down the system if a dangerous situation arises. For example, a maximum safe temperature of working fluid has been quoted as being about 45° C. If this temperature were exceeded, the system may be designed to shut itself down or even turn itself off. Alternatively, a high temperature may be allowed, but only for a short predetermined period of time.

[0054] In another reference source, the mucosa in the bladder lining has been noted as being damaged after exposure to 43° C. working fluid for four hours. The “pain threshold” has been noted as 42.5° C. A “mixed fluid” temperature may be defined as that which exits the bladder, and corresponds to the temperature of fluid after the effect of mixing with existing fluid in the bladder as well as with the urine. Rather than relying for safety on a lowering of the working fluid temperature upon entering the bladder, another suitable procedure may be to set the temperature of the working fluid as high as possible, without damaging tissue, for its entry into the bladder. This would correspond to a maximum heat transfer condition. That is, the effect of mixing can only be to lower the temperature and lessen the heat transfer. Then the flow rate may be set as high as possible, again without damaging the tissue. A typical flow rate may be, e.g., about 4-5 cubic centimeters of working fluid per second. Animal experiments have shown that such flow rates may lead to about 100-120 Watts of cooling, at 2½ to 3½° C. per hour, for an animal of 40 kg. Animal experiments have also shown that such flow rates may lead to about 40 Watts of heating for an animal of 40 kg.

[0055] In a cooling regime, a suitable range of extreme low temperatures may be about 10-12° C. In particular, these temperatures would be for the temperature of the working fluid as it enters the bladder. In this regime, the temperature may be chosen to be high enough so as to not cause uric acid crystallization, etc. The circulation set 28 depicted in FIGS. 1 and 2 recirculates the heat transfer fluid so that it flows through the bladder 11 a multiple of times. In this case the heat transfer fluid would include urine that has accumulated in the bladder 11 and been conducted through the return lumen of the catheter. In other embodiments of the invention, however, the circulation set 28 may continuously replenish the supply of heat transfer fluid so that the bladder 11 is irrigated with fresh heat transfer fluid. In this case the heat transfer fluid is disposed of after being flushed from the bladder 11 by the catheter.

[0056] It is generally important during many surgical procedures to monitor the flow of urine to assess the overall physiologic balance of the patient and to ensure that renal failure does not occur. That is, if a patient is receiving an infusion of a given amount of fluid, urine monitoring should be performed to ensure that the patient is properly processing the fluid. Dangerous situations could arise if the patient were not maintaining proper hydration or if the patient were taking in fluid other than through the vasculature or the gastrointestinal system, such as the lungs, for example. This so-called “third spacing” of the fluid may lead to a hazardous situation warranting immediate intervention. In addition, renal ischemic injury such as acute tubular necrosis (ATN) can arise. If this occurs, the patient may be given the opportunity to eliminate the fluid on his or her own. That is, if the kidneys 15 (FIG. 3) fail, they may simply flush out the remaining fluid, after which no more fluid would be produced.

[0057] The typical urine output from a 70 kg patient has been measured to be about 70 ml/hour up to about a liter per day (0.6 cc/hr/kg). Of course, these numbers may vary according to the patient. Accordingly, during the procedure the volume of fluid returning from the bladder 11 in the circulation set should be monitored to ensure that it increases at the expected rate. If the volume of urine does not increase as expected, the patient may be undergoing renal failure and the procedure should be stopped so that appropriate action can be taken.

[0058] The urine output volume may be measured in a number of different ways. For example, in one embodiment of the invention in which the heat transfer fluid is recirculated, the urine output may be monitored simply by observing the change in fluid level in the fluid reservoir 60. Alternatively, or in addition thereto, the fluid level may be electronically or optically detected by a sensor so that it can be monitored by the control unit 26.

[0059] If the fluid is disposed of after being flushed from the bladder 11, control unit 26 can determine the quantity or rate of urine output simply by measuring the differential between the quantity or rate of fluid flowing into the bladder 11 and flowing out of the bladder 11 once the bladder 11 has been initially filled.

[0060] In some embodiments of the invention the control unit may automatically adjust the fluid flow rate in response to the measured urine volume. Some factors that may be considered in determining the appropriate relationship between the fluid flow rate and the urine volume will be presented below.

[0061] The volume of fluid supplied by the catheter and residing in the bladder 11 must not be so great that it upsets the physiologic balance in the bladder 11. In particular, the volume of fluid should not be so great that it exerts a pressure on the walls of the bladder 11 that prevents the flow of urine from the ureters 13 (FIG. 3) into the bladder 11. This pressure should typically be less than about 0.28-0.85 psi. One way of ensuring that this does not occur is to monitor the urine flow in the manner previously described. However, another technique may be to directly measure the pressure of the fluid in the supply line before it enters the catheter and in the return line after it leaves the catheter. It can be shown that, in the steady state, where the small urine production is ignored, that:

p_{BLADDER} = \frac{p_{SUPPLY} + p_{RETURN}}{2} - \frac{Δ p_{SUPPLY} (Q) - Δ p_{RETURN} (Q)}{2}

[0062] where P_SUPPLYis the supply pressure, P_RETURNis the return pressure, P_BLADDERis the bladder pressure, Q is the supply and return heat flux (in the steady state), Δp_SUPPLY(Q) is the pressure drop on the supply lumen, and Δp_RETURN(Q) is the pressure drop on the return lumen.

[0063] In the case of identical supply and return lumens, this reduces to (as Δp_SUPPLY(Q)=Δp_RETURN(Q))

p_{BLADDER} = \frac{p_{SUPPLY} + p_{RETURN}}{2}

[0064] While it may be only strictly necessary to monitor either the urine flow rate or the pressure of the fluid, in general it will be advantageous to monitor both flow rate and pressure. In this way, the occurrence of both overpressurization of the bladder 11 and renal failure can be detected. If only pressure is monitored, the occurrence of renal failure may be missed. If only flow is monitored, the bladder may become over-pressurized.

[0065] The fluid may be provided to the supply lumen in a continuous, constant flow or as a pulsed flow of fluid. The pulsed flow may be a flow that is either intermittently interrupted or simply reduced in rate on an intermittent basis. A pulsed flow rate will allow urine that has accumulated in the bladder 11 to be flushed out. For example, the flow rate may be pulsed so that the bladder 11 is flushed at a regular interval, e.g., every few minutes. The present invention also contemplates more complex flow rate patterns such as periodic and aperiodic oscillatory patterns, for example. If a constant flow is used, it should be sufficiently low to ensure that the pressure in the bladder 11 is not so great that urine cannot be flushed from the bladder 11. That is, the bladder 11 pressure should be less than the pressure in the ureter 13 so that urine flow from the kidneys 15 to the bladder 11 is not prevented. Of course, in many cases it will be desirable to maintain as great a flow of fluid as possible to maximize the rate of heat exchange. If a pulsed flow is used, the pressure exerted upon the bladder 11 by each pulse may exceed the pressure that can be used in a continuous flow. However, the duration between the pulses should be sufficiently great so that urine flows out of the bladder 11 to allow drainage of the kidneys 15. The flow rate can be controlled by control unit 26 based on the information received from the temperature and/or pressure assembly 76, the values of the user input parameters received via user input keys 40, the value of pressure in the bladder measured by pressure monitor 77, or the volume or rate of urine flow out of the bladder 11.

[0066] Returning to FIGS. 3-8, which show the distal end of the catheter inserted in the bladder 11, a variety of different tips 116 may be provided over supply orifice 110 to facilitate distribution of the fluid in the bladder 11 so that the bladder 11 is thoroughly irrigated. For example, as shown in FIG. 10, tip 116a may be a diffuser that distributes the fluid in substantially all directions. The diffusing tip 116a may be formed, for example, from a porous material or an impermeable material having a series of orifices distributed over its surface.

[0067] FIG. 11 shows another tip design that employs a floating ball valve 116b. Floating ball valve 116b includes a slidable ball 117 whose movement is constrained by cage 118, which extends outward from the supply orifice 110. When fluid exits the supply orifice 110, the fluid exerts pressure on the slidable ball 117 so that the ball moves away from the orifice 110, forcing the fluid to flow out of the valve in a dispersed manner. Moreover, the floating ball valve 116b advantageously prevents substantial amounts of fluid from flowing back into the supply orifice 110 when no fluid is flowing up through the catheter. This is because when no fluid is exiting supply orifice 110, any backflow of fluid into the supply orifice 110 will cause the ball 117 to move toward, and close off, the orifice 110 as a result of the fluid's viscosity and the resulting region of reduced pressure that develops between the ball 117 and the supply orifice 110.

[0068] FIG. 12 shows yet another embodiment of the invention that employs a deflector tip 116c that has a surface 119 opposing the plane of the supply orifice 110, which deflects the fluid as it exits the orifice 110 so that it is distributed over a complete 360 region. The deflector tip 116c, which is preferably formed from a pliable material, is fixed to an insert (not shown) positioned in the supply orifice 110.

[0069] FIG. 13 illustrates a cross-section of the tip of FIG. 12, and shows four roughly perpendicular fluid paths 165 emerging from four supply lumens 166. The four supply lumens 166 may all emerge themselves from supply lumen 106. In other words, supply lumen 106 may be split into four separate lumens 166 to allow four mutually perpendicular or independent flows 165 to emerge. As the insertion of a Foley-type catheter is generally uncomplicated, and can be performed by nurses or emergency personnel, embodiments of the invention may be implemented on an emergency vehicle such as an ambulance. One aspect allowing this may be inclusion in certain embodiments of a compressed gas system to cool a circulating fluid. It is again noted that in heating embodiments a simple resistive heater may be employed.

[0070] Prior chiller units employing a closed cycle evaporative gas system were complicated, expensive, and difficult to simplify and miniaturize for use in a portable transportable system. Further, they required significant electrical power to operate. For example, referring to FIG. 14A, a prior art refrigeration system 200 is shown. Such a system is exceedingly well-known, and includes a pump 202, a heat exchanger 204, a restriction valve 208, and an apparatus 206 to exhaust heat to a temperature bath. In this system, as is known, a liquid to gas heat exchanger transfers heat from the working fluid to the cold side of an evaporative chiller.

[0071] A system 201 according to an embodiment of the present invention is shown in FIG. 14B. In this figure, a source of compressed gas 218 is valvably coupled via valve 220 to an optional restriction valve 222 to a heat exchanger 224. A working fluid output for, e.g., cold working fluid, is labeled by outlet 214. A working fluid input for, e.g., hot working fluid, is labeled by inlet 216. An exhaust to the environment is shown as exhaust 226.

[0072] In system 201, a compressed gas from source 218 is expanded adiabatically through a valve. The expansion results in a reduced temperature gas that absorbs heat from the working fluid in the liquid-to-gas heat exchanger 224. The heated, expanded gas is then discarded to the environment via exhaust 226. A additional temperature reduction in the expanded gas may be achieved by the phase change from the storage pressure to the expanded pressure.

[0073] Gases which may be useful in embodiments of the invention employing adiabatic expansion include nitrogen, carbon dioxide, etc. Gases which may be useful in embodiments of the invention employing adiabatic expansion with a phase change include nitrous oxide.

[0074] Of course, it should be noted that the above portable heat exchange system may be employed not only in the above bladder cooling embodiment but may also be employed as a heat exchange system for various other heat exchange catheters, including that disclosed in U.S. Pat. No. 6,096,068, incorporated above by reference in its entirety, or that disclosed in U.S. application Ser. No. 09/373,112, also incorporated by reference in its entirety.

[0075] While the invention herein disclosed is capable of obtaining the objects hereinbefore stated, it is to be understood that this disclosure is merely illustrative of the presently preferred embodiments of the invention and that no limitations are intended other than as described in the appended claims. For example, the invention can be used in a wide variety of settings, e.g., in the applications of general surgery, and in particular lengthy surgeries, orthopedic and back surgery, liver transplants, etc.

Claims

1. A catheter, comprising:

a manifold having a proximal end with at least first and second input ports and a distal end with at least first and second output ports;

at least first and second flexible tubes defining a supply lumen and a return lumen, respectively, said first and second flexible tubes having proximal ends removably connectable to the output ports of the manifold and having distal ends with a supply and return orifice, respectively; and

a dispersing element associated with the supply orifice for dispersing fluid exiting the supply orifice into a portion of the body.

2. The catheter of claim 1, wherein said dispersing element is a diffusing element.

3. The catheter of claim 1, wherein said dispersing element is a floating ball valve.

4. The catheter of claim 1, wherein said dispersing element is a deflecting element.

5. The catheter of claim 1, wherein said return orifice is spatially separated from said supply orifice.

6. The catheter of claim 5, wherein said spatial separation between said supply and return orifices is sufficient to prevent a substantial flow of fluid directly from said supply orifice to said return orifice.

7. The catheter of claim 1, further comprising an inflatable balloon for maintaining an operative position of said tubes when inserted into a patient.

8. The catheter of claim 1, wherein said first and second flexible tubes are concentrically oriented with respect to one another.

9. A Foley catheter for heating or cooling at least a selected portion of a body, comprising:

a catheter for irrigating and evacuating the bladder with a heated or chilled fluid, the catheter including:

a manifold having a proximal end with at least first and second input ports and a distal end with at least first and second output ports;

means, coupled to the catheter, for controlling at least one measurable parameter of the fluid irrigating the bladder; and

means for monitoring at least one parameter selected from the group consisting of: the at least one measurable parameter of fluid flowing out of the bladder while it is being irrigated, a core temperature of the body, and a pressure of the combined heated or chilled fluid and urine in the bladder.

10. The catheter of claim 9, further comprising an inflatable balloon coupled to said catheter for maintaining an operative position of said catheter when inserted into a patient.

11. The catheter of claim 9, wherein the means for monitoring the core temperature of the body is an esophageal temperature probe.

12. The catheter of claim 9, wherein the means for monitoring the core temperature of the body is a tympanic temperature probe.

13. The catheter of claim 9, wherein the means for monitoring the pressure of the bladder is a pressure transducer mounted adjacent the distal tip of the catheter.

14. The catheter of claim 9, wherein the at least one measurable parameter of fluid flowing out of the bladder is the output of urine.

15. The catheter of claim 9, further comprising a sensor for measuring the output of urine.

16. The catheter of claim 15, wherein the sensor is an optical sensor.

Patent Citations (287)

Patent	Date	Inventor	Cited By
US2672032(A)	1954-03-01	Towse	Applicant
US2913009(A)	1959-11-01	Kuthe	Applicant
US3125096(A)	1964-03-01	Antiles et al.	Applicant
US3425419(A)	1969-02-01	Dato	Applicant
US3612175(A)	1971-10-01	Ford et al.	Applicant
US4038519(A)	1977-07-01	Foucras	Applicant
US4190033(A)	1980-02-01	Foti	Applicant
US4298006(A)	1981-11-01	Parks	Applicant
US4323071(A)	1982-04-01	Simpson et al.	Applicant
US4602642(A)	1986-07-01	O'Hara et al.	Applicant
US4745922(A)	1988-05-01	Taylor	Applicant
US4747826(A)	1988-05-01	Sassano	Applicant
US4762129(A)	1988-08-01	Bonzel	Applicant
US4781799(A)	1988-11-01	Herbert, Jr. et al.	Applicant
US4820349(A)	1989-04-01	Saab	Applicant
US4951677(A)	1990-08-01	Crowley et al.	Applicant
US4964409(A)	1990-10-01	Tremulis	Applicant
US5000734(A)	1991-03-01	Boussignac et al.	Applicant
US5002531(A)	1991-03-01	Bonzel	Applicant
US5014695(A)	1991-05-01	Benak et al.	Applicant
US5024668(A)	1991-06-01	Peters et al.	Applicant
US5046497(A)	1991-09-01	Millar	Applicant
US5078736(A)	1992-01-01	Behl	Applicant
US5089260(A)	1992-02-01	Hunter et al.	Applicant
US5100388(A)	1992-03-01	Behl et al.	Applicant
US5106368(A)	1992-04-01	Uldall	Applicant
USRE33911(E)	1992-05-01	Samson et al.	Applicant
US5112438(A)	1992-05-01	Bowers	Applicant
US5150706(A)	1992-09-01	Cox et al.	Applicant
US5180364(A)	1993-01-01	Ginsburg	Applicant
US5183464(A)	1993-02-01	Dubrul et al.	Applicant
US5188602(A)	1993-02-01	Nichols	Applicant
US5190539(A)	1993-03-01	Fletcher et al.	Applicant
US5211631(A)	1993-05-01	Sheaff	Applicant
US5222938(A)	1993-06-01	Behl	Applicant
US5241951(A)	1993-09-01	Mason et al.	Applicant
US5250033(A)	1993-10-01	Evans et al.	Applicant
US5257977(A)	1993-11-01	Eshel	Applicant
US5267341(A)	1993-11-01	Shearin	Applicant
US5269758(A)	1993-12-01	Taheri	Applicant
US5275611(A)	1994-01-01	Behl	Applicant
US5306261(A)	1994-04-01	Alliger et al.	Applicant
US5312360(A)	1994-05-01	Behl	Applicant
US5330519(A)	1994-07-01	Mason et al.	Applicant
US5383854(A)	1995-01-01	Safar et al.	Applicant
US5392766(A)	1995-02-01	Masterson et al.	Applicant
US5395331(A)	1995-03-01	O'Neill et al.	Applicant
US5411477(A)	1995-05-01	Saab	Applicant
US5423807(A)	1995-06-01	Milder	Applicant
US5431676(A)	1995-07-01	Dubrul et al.	Applicant
US5437673(A)	1995-08-01	Baust et al.	Applicant
US5443456(A)	1995-08-01	Alliger et al.	Applicant
US5454790(A)	1995-10-01	Dubrul	Applicant
US5464437(A)	1995-11-01	Reid et al.	Applicant
US5486208(A)	1996-01-01	Ginsburg	Applicant
US5496271(A)	1996-03-01	Burton et al.	Applicant
US5531776(A)	1996-07-01	Ward et al.	Applicant
US5540658(A)	1996-07-01	Evans et al.	Applicant
US5549559(A)	1996-08-01	Eshel	Applicant
US5554119(A)	1996-09-01	Harrison et al.	Applicant
US5558644(A)	1996-09-01	Boyd et al.	Applicant
US5573532(A)	1996-11-01	Chang et al.	Applicant
US5578008(A)	1996-11-01	Hara	Applicant
US5584804(A)	1996-12-01	Klatz et al.	Applicant
US5588438(A)	1996-12-01	McKown et al.	Applicant
US5622182(A)	1997-04-01	Jaffe	Applicant
US5624392(A)	1997-04-01	Saab	Applicant
US5630837(A)	1997-05-01	Crowley	Applicant
US5643197(A)	1997-07-01	Brucker et al.	Applicant
US5643335(A)	1997-07-01	Reid et al.	Applicant
US5649973(A)	1997-07-01	Tierney et al.	Applicant
US5653692(A)	1997-08-01	Masterson et al.	Applicant
US5709654(A)	1998-01-01	Klatz et al.	Applicant
US5733318(A)	1998-03-01	Augustine	Applicant
US5733319(A)	1998-03-01	Neilson et al.	Applicant
US5799661(A)	1998-09-01	Boyd et al.	Applicant
US5800493(A)	1998-09-01	Stevens et al.	Applicant
US5800516(A)	1998-09-01	Fine et al.	Applicant
US5807391(A)	1998-09-01	Wijkamp	Applicant
US5820593(A)	1998-10-01	Safar et al.	Applicant
US5824030(A)	1998-10-01	Yang et al.	Applicant
US5827222(A)	1998-10-01	Klatz et al.	Applicant
US5827269(A)	1998-10-01	Saadat	Applicant
US5836913(A)	1998-11-01	Orth et al.	Applicant
US5837003(A)	1998-11-01	Ginsburg	Applicant
US5861021(A)	1999-01-01	Thome et al.	Applicant
US5868735(A)	1999-02-01	Lafontaine	Applicant
US5871526(A)	1999-02-01	Gibbs et al.	Applicant
US5873835(A)	1999-02-01	Hastings et al.	Applicant
US5879316(A)	1999-03-01	Safar et al.	Applicant
US5879329(A)	1999-03-01	Ginsburg	Applicant
US5891094(A)	1999-04-01	Masterson et al.	Applicant
US5899898(A)	1999-05-01	Arless et al.	Applicant
US5899899(A)	1999-05-01	Arless et al.	Applicant
US5902268(A)	1999-05-01	Saab	Applicant
US5906588(A)	1999-05-01	Safar et al.	Applicant
US5906594(A)	1999-05-01	Scarfone et al.	Applicant
US5906636(A)	1999-05-01	Casscells, III et al.	Applicant
US5913856(A)	1999-06-01	Chia et al.	Applicant
US5913885(A)	1999-06-01	Klatz et al.	Applicant
US5913886(A)	1999-06-01	Soloman	Applicant
US5957917(A)	1999-09-01	Doiron et al.	Applicant
US5957963(A)	1999-09-01	Dobak, III	Applicant
US5964751(A)	1999-10-01	Amplatz et al.	Applicant
US5968009(A)	1999-10-01	Siman	Applicant
US5971979(A)	1999-10-01	Joye et al.	Applicant
US5989238(A)	1999-11-01	Ginsburg	Applicant
US6007692(A)	1999-12-01	Herbert et al.	Applicant
US6019783(A)	2000-02-01	Philips et al.	Applicant
US6022336(A)	2000-02-01	Zadno-Azizi et al.	Applicant
US6024740(A)	2000-02-01	Lesh et al.	Applicant
US6033383(A)	2000-03-01	Ginsburg	Applicant
US6042559(A)	2000-03-01	Dobak, III	Applicant
US6051019(A)	2000-04-01	Dobak, III	Applicant
US6063101(A)	2000-05-01	Jacobsen et al.	Applicant
US6096068(A)	2000-08-01	Dobak, III et al.	Applicant
US6110168(A)	2000-08-01	Ginsburg	Applicant
US6126684(A)	2000-10-01	Gobin et al.	Applicant
US6146411(A)	2000-11-01	Noda et al.	Applicant
US6146814(A)	2000-11-01	Millet	Applicant
US6149670(A)	2000-11-01	Worthen	Applicant
US6149673(A)	2000-11-01	Ginsburg	Applicant
US6149676(A)	2000-11-01	Ginsburg	Applicant
US6149677(A)	2000-11-01	Dobak, III	Applicant
US6165207(A)	2000-12-01	Balding et al.	Applicant
US6194899(B1)	2001-02-01	Ishihara et al.	Applicant
US6224624(B1)	2001-05-01	Lasheras et al.	Applicant
US6231594(B1)	2001-05-01	Dae	Applicant
US6231595(B1)	2001-05-01	Dobak, III	Applicant
US6235048(B1)	2001-05-01	Dobak, III	Applicant
US6238428(B1)	2001-05-01	Werneth et al.	Applicant
US6245095(B1)	2001-06-01	Dobak et al.	Applicant
US6251129(B1)	2001-06-01	Dobak et al.	Applicant
US6251130(B1)	2001-06-01	Dobak et al.	Applicant
US6254626(B1)	2001-07-01	Dobak et al.	Applicant
US6261312(B1)	2001-07-01	Dobak et al.	Applicant
US6264679(B1)	2001-07-01	Keller et al.	Applicant
US6264680(B1)	2001-07-01	Ash	Applicant
US6287326(B1)	2001-09-01	Pecor	Applicant
US6290697(B1)	2001-09-01	Tu et al.	Applicant
US6290717(B1)	2001-09-01	Philips	Applicant
US6295990(B1)	2001-10-01	Lewis et al.	Applicant
US6299599(B1)	2001-10-01	Pham et al.	Applicant
US6303156(B1)	2001-10-01	Ferrigno	Applicant
US6306161(B1)	2001-10-01	Ginsburg	Applicant
US6312452(B1)	2001-11-01	Dobak et al.	Applicant
US6325818(B1)	2001-12-01	Werneth	Applicant
US6338727(B1)	2002-01-01	Noda et al.	Applicant
US6364899(B1)	2002-04-01	Dobak, III	Applicant
US6368304(B1)	2002-04-01	Aliberto et al.	Applicant
US6379378(B1)	2002-04-01	Werneth et al.	Applicant
US6383210(B1)	2002-05-01	Magers et al.	Applicant
US6393320(B2)	2002-05-01	Lasersohn et al.	Applicant
US6406452(B1)	2002-06-01	Westerbeck	Applicant
US6416545(B1)	2002-07-01	Mikus et al.	Applicant
US6602243(B2)	2003-08-01	Noda	Applicant
US6645233(B1)	2003-11-01	Ayers et al.	Applicant
US6648906(B2)	2003-11-01	Lasheras et al.	Applicant
US2001/0001064(A1)	2001-05-01	Holaday	Applicant
US2001/0001830(A1)	2001-05-01	Dobak, III et al.	Applicant
US2001/0001831(A1)	2001-05-01	Dobak, III et al.	Applicant
US2001/0001832(A1)	2001-05-01	Dobak, III et al.	Applicant
US2001/0002442(A1)	2001-05-01	Dobak, III	Applicant
US2001/0005791(A1)	2001-06-01	Ginsburg et al.	Applicant
US2001/0007951(A1)	2001-07-01	Dobak, III	Applicant
US2001/0008975(A1)	2001-07-01	Dobak, III et al.	Applicant
US2001/0010011(A1)	2001-07-01	Aliberto et al.	Applicant
US2001/0011184(A1)	2001-08-01	Dobak, III et al.	Applicant
US2001/0011185(A1)	2001-08-01	Dobak, III et al.	Applicant
US2001/0016763(A1)	2001-08-01	Lasheras et al.	Applicant
US2001/0016764(A1)	2001-08-01	Dobak et al.	Applicant
US2001/0021865(A1)	2001-09-01	Dobak, III et al.	Applicant
US2001/0021866(A1)	2001-09-01	Dobak, III et al.	Applicant
US2001/0029394(A1)	2001-10-01	Dobak, III et al.	Applicant
US2001/0031946(A1)	2001-10-01	Walker et al.	Applicant
US2001/0032004(A1)	2001-10-01	Werneth	Applicant
US2001/0039440(A1)	2001-11-01	Lasheras et al.	Applicant
US2001/0041923(A1)	2001-11-01	Dobak, III	Applicant
US2001/0044644(A1)	2001-11-01	Keller et al.	Applicant
US2001/0047191(A1)	2001-11-01	Lasersohn et al.	Applicant
US2001/0047192(A1)	2001-11-01	Lasersohn et al.	Applicant
US2001/0047196(A1)	2001-11-01	Ginsburg et al.	Applicant
US2002/0002394(A1)	2002-01-01	Dobak, III	Applicant
US2002/0004675(A1)	2002-01-01	Lasheras	Applicant
US2002/0007179(A1)	2002-01-01	Dobak, III et al.	Applicant
US2002/0007202(A1)	2002-01-01	Dobak, III et al.	Applicant
US2002/0007203(A1)	2002-01-01	Gilmartin et al.	Applicant
US2002/0016621(A1)	2002-02-01	Werneth et al.	Applicant
US2002/0022823(A1)	2002-02-01	Luo et al.	Applicant
US2002/0026227(A1)	2002-02-01	Philips	Applicant
US2002/0029016(A1)	2002-03-01	Pham et al.	Applicant
US2002/0032430(A1)	2002-03-01	Lucetal	Applicant
US2002/0032474(A1)	2002-03-01	Dobak, III et al.	Applicant
US2002/0040717(A1)	2002-04-01	Dobak, III	Applicant
US2002/0045892(A1)	2002-04-01	Kramer	Applicant
US2002/0045925(A1)	2002-04-01	Keller et al.	Applicant
US2002/0049409(A1)	2002-04-01	Noda et al.	Applicant
US2002/0049410(A1)	2002-04-01	Noda et al.	Applicant
US2002/0049484(A1)	2002-04-01	Werneth et al.	Applicant
US2002/0077680(A1)	2002-06-01	Noda et al.	Applicant
US2002/0082671(A1)	2002-06-01	Magers	Applicant
US2003/0114835(A1)	2003-06-01	Noda	Applicant
US2004/0102826(A1)	2004-05-01	Lasheras et al.	Applicant
AU730835(B2)	2001-03-01		Applicant
AU734506(B2)	2001-07-01		Applicant
AU739996(B2)	2001-10-01		Applicant
AU743945(B2)	2002-02-01		Applicant
CA2042026	1991-03-01		Applicant
EP444184(B1)	1996-02-01		Applicant
WO91/03996	1991-04-01		Applicant
WO91/05528	1991-05-01		Applicant
WO91/16864	1991-11-01		Applicant
WO92/08513	1992-05-01		Applicant
WO92/20290	1992-11-01		Applicant
WO92/20399	1992-11-01		Applicant
WO94/20026	1994-09-01		Applicant
WO95/01814	1995-01-01		Applicant
WO96/00105	1996-01-01		Applicant
WO96/40347	1996-12-01		Applicant
WO97/01374	1997-01-01		Applicant
WO97/09010	1997-03-01		Applicant
WO97/25011	1997-07-01		Applicant
WO97/42991	1997-11-01		Applicant
WO97/43958	1997-11-01		Applicant
WO98/06448	1998-02-01		Applicant
WO98/26831	1998-06-01		Applicant
WO98/31312	1998-07-01		Applicant
WO98/50104	1998-11-01		Applicant
WO95/30449	1998-12-01		Applicant
WO98/57603	1998-12-01		Applicant
WO99/02194	1999-01-01		Applicant
WO99/37226	1999-07-01		Applicant
WO99/48449	1999-09-01		Applicant
WO99/66970	1999-12-01		Applicant
WO99/66971	1999-12-01		Applicant
WO/02616	2000-01-01		Applicant
WO1/03606	2000-01-01		Applicant
WO/06243	2000-02-01		Applicant
WO/09054	2000-02-01		Applicant
WO/10494	2000-03-01		Applicant
WO/38601	2000-07-01		Applicant
WO/40619	2000-07-01		Applicant
WO/47145	2000-08-01		Applicant
WO/48670	2000-08-01		Applicant
WO/51534	2000-09-01		Applicant
WO/53135	2000-09-01		Applicant
WO/57823	2000-10-01		Applicant
WO/62837	2000-10-01		Applicant
WO/66053	2000-11-01		Applicant
WO/69350	2000-11-01		Applicant
WO/72779	2000-12-01		Applicant
WO/72787	2000-12-01		Applicant
WO1/08580	2001-02-01		Applicant
WO1/10323	2001-02-01		Applicant
WO1/10365	2001-02-01		Applicant
WO1/12061	2001-02-01		Applicant
WO1/12122	2001-02-01		Applicant
WO1/13809	2001-03-01		Applicant
WO1/13837	2001-03-01		Applicant
WO1/17471	2001-03-01		Applicant
WO1/19447	2001-03-01		Applicant
WO1/26590	2001-04-01		Applicant
WO1/30413	2001-05-01		Applicant
WO1/41708	2001-06-01		Applicant
WO1/43661	2001-06-01		Applicant
WO1/49236	2001-07-01		Applicant
WO1/52781	2001-07-01		Applicant
WO1/56517	2001-08-01		Applicant
WO1/58397	2001-08-01		Applicant
WO1/64145	2001-09-01		Applicant
WO1/64146	2001-09-01		Applicant
WO1/66052	2001-09-01		Applicant
WO1/74276	2001-10-01		Applicant
WO1/76655	2001-10-01		Applicant
WO1/78580	2001-10-01		Applicant
WO1/87379	2001-11-01		Applicant
WO1/95840	2001-12-01		Applicant
WO2/07793	2002-01-01		Applicant
WO2/26175	2002-04-01		Applicant
WO2/26176	2002-04-01		Applicant
WO2/26285	2002-04-01		Applicant
WO2/26307	2002-04-01		Applicant
WO2/28300	2002-04-01		Applicant
WO2/36180	2002-05-01		Applicant
WO2/38091	2002-05-01		Applicant
WO2/47577	2002-06-01		Applicant
WO2/47742	2002-06-01		Applicant

Non-Patent Literature (57)

Allen, Terry D., “Body Temperature Changes During Prostatic Resection as Related to the Temperature of the Irrigating Solution,” The Journal of Urology, vol. 110, Oct. 1973, pp. 433-435.Applicant
Ambrus, “The Biphasic Nature and Temperature Dependence of the Activation of Human Plasminogen by Urokinase,” Research Communications in Chemical Pathology and Pharmacology, vol. 24, No. 2, May, 1979, pp. 339-347.Applicant
Behmann, F.W., et al.; α Heat Generation Control during Artificial Hypothermia: I: Experimental Examination of the Influence of Anesthetic Depth; Pflügers Archiv, Bd. 266, S. 408-421 (1958) (German article with English translation).Applicant
Behmann, F.W., et al.; Intravascular Cooling, a Method to Achieve Controllable Hypothermia; Pflügers Archive, vol. 263, pp. 145-165 (1956) (German article with English translation).Applicant
Behmann, F.W.; “Heat Generation Control during Artificial Hypothermia, an article about the economic problem of trembling stages”; Pflügers Archive, vol. 263, pp. 166-187 (1956) (German article with English translation).Applicant
Behmann, F.W; “Heat Generation Control during Artificial Hypothermia: II. Theoretical Examinations”; Pflügers Archiv, Bd. 266, S. 422-446 (1958) (German article with English translation).Applicant
Bigelo, “Hypothermia, Its Possible Role in Cardiac Surgery,” Annals of Surgery, vol. 132, No. 5, Nov., 1959, pp. 849-866.Applicant
Bone, M.E., et al.; “Bladder Temperature as an Estimate of Body Temperature During Cardiopulmonary Bypass”; Anaesthesia; vol. 43; pp. 181-185 (1988).Applicant
Cancio, Leopoldo C. et al., “Trauma: Peritoneal Dialysis to Induce Hypothermia in a Head-Injured Patient: Case Report,” Surg. Neurol. 42: 303-7, 1994.Applicant
Cheatle, “Cryostripping the Long and Short Saphenous Veins,” Br. J. Surg., vol. 80, Jan. 1993.Applicant
Colvett, K. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer. Journal of surgical oncology, vol. 63, No. 3, pp. 201-208, 1996.Applicant
Dexter, “Blood Warms as it Blows Retrograde from a Femoral Cannulation Site to the Carotid Artery During Cardiopulmonary Bypass,” Perfusion, vol. 9, No. 6, Nov. 1994, pp. 393-397.Applicant
Dr. Gravenstein, Temperature, Clinical Monitoring Practices, pp. 208-210.Applicant
Elenor R. Adair, Thermoregulation IN the Presence of Microwave Fields, Handbook of Biological Effects of Electromagnetic Fields, Chapter 10, pp. 403-433.Applicant
England H.R., et al., “The Therapeutic Application of Hyperthermia in the Bladder,” British Journal of Urology, pp. 849-852.Applicant
Gillinov, “Superior Cerebral Protection with Profound Hypothermia During Circulatory Arrest,” Ann. Thorac. Surg., vol. 55, Nov. 1992, pp. 1432-1439.Applicant
Gomella, Leonard G., et al., “A Large Clinical Manual: Clinician's Pocket Reference”, 6th Edition, pp. 98-106, and 126-130.Applicant
Hall, R.R., et al., “Hyperthermia in the Treatment of Bladder Tumours,” British journal of Urology, vol. 48, 1976, pp. 603-608.Applicant
Hayes, B., et al., “Temperature Control in Extracorporeal Circulation” 1968.Applicant
Hederer, G., et al.; “Animal Experiment Observations Regarding Cardiac Surgery under Intravascular Hypothermia”; Labgebbecjs Arch. U. Dtsch. A. Chir., Bd. 283, S. 601-625 (1957) (German article with English translation).Applicant
Higazi, “The Effect of Ultrasonic Irradiation and Temperature on Fibrinolytic Activity in Vitro,” thrombosis Research, vol. 69, No. 2, Aug. 1992, pp. 251-253.Applicant
Imamaki, “Retrograde Cerebral Perfusion with Hypothermic Blood Provides Efficient Protection of the Brain,” Journal of Cardiac Surgery, vol. 10, No. 4, Part 1, Jul. 1995, pp. 325-333.Applicant
Jackson, Donald, et al; “Hypothermia : IV. Study of Hypothermia Induction Time with Various Pharmacological Agents (24617)”; Proc Soc Exp Biol Med.; 100(2): 332-335 (Feb. 1959).Applicant
Jolin, “Management of a Giant Intracranial Aneurysm Using Surface-Heparinized Extracorporeal Circulation and Controlled Deep Hypothermic Low Flow Perfusion,” Acta Anaesthesiologica Scandinavia, Aug. 1992, pp. 756-760.Applicant
Joseph R.C. Jansen, PhD et al., “Near Continuous Cardiac Output by Thermodilution,” Journal of Clinical Monitoring, vol. 13:233-239.Applicant
Kapp, Daniel S., et al., “Bladder Cooling in Patients Treated with Regional Hyperthermia of the Pelvis Using an Annular Phased Array,” International Journal Radiation Oncology Biology Physics, vol. 14, No. 6, Jun. 1988, pp. 1307-1310.Applicant
Kimoto, “Open Heart surgery Under Direct Vision with the Aid of Brain-Cooling by Irrigation,” Surgery, vol. 39, No. 4, Jul. 1955, pp. 592-603.Applicant
Kubota, Yoshinobu, et al., “Treatment of Bladder Cancer with a Combination of Hyperthermia, Radiation and Bleomycin,” Cancer, vol. 53, 1984, pp. 199-202.Applicant
Ludgate, C.N. et al. “Hypterthemic Perfusion of the Distended Urinary Bladder int eh Managemetn of Recurrent Transitional Cell Carcinoma,” British Journal of Urology, vol. 47, 1976, pp. 841-848.Applicant
Ludgate, C.N. et al., “Hyperthermic irrigation of bladder in treatment of transitional cell carcinoma: its effectiveness in controlling persistent haematurial,” Joural of the Royal Society of Medicine, vol. 72, May 1979, pp. 336-340.Applicant
Lunglmayr, G., et al. “Bladder Hyperthermia in the Treatment of Vesical Papillomatosis,” International Urology and Nephrology, vol. 5, No. 1, 1973, pp. 75-84.Applicant
Maas, C. Intermittent antegrade selective cerebral perfusion during circulatory arrest for repair of aortic arch. Perfusion, vol. 12, No. 2, pp. 127-132, 1997.Applicant
Marekovic, Z., Abstract of “Renal Hypothermia in Situ by Veneous Passages: Experimental Work on Dogs,” Eur Urol 6(2), 1980, 1 page.Applicant
Meden, “Effect of Hypothermia and Delayed Thrombolysis in a Rat Embolic Stroke Model,” Acta Neruologica Scandinavica, Dec. 1993, pp. 91-98.Applicant
Meden, “The Influence of Body Temperature on Infarct Volume and Thromolytic Therapy in a Rat embolic Stroke Model,” Brain Research, vol. 647, Feb. 1994, pp. 131-138.Applicant
Milleret, Abstract of “Cryosclerosis of the Saphenous Veins in Varicose Reflux in the Obese and Elderly,” Phlebologie, vol. 34, No. 4, Oct. 1981, one page.Applicant
Milleret, Rene, “La-cryo-chirurgie danes les varices des mimbres inferieurs,” Angiologie, Supplement No. 110.Applicant
Monga, M. et al., “Effect of irrigating fluid on perioperative temperature regulation during transurethral prostatectomy,” Abstract, Eur Urol 1996, vol. 29(1):26-28.Applicant
Netto, I.C.V. et al., “Marked Hyperthermia Effect on Male Canine Urinary Bladder,” Urology, vol. 1, No. 4, Apr. 1973, pp. 347-350.Applicant
Nissenkorn, I. et al., “Temperature Measurements and Histology of the Canine Prostate During Transurethral Hyperthermia,” The Journal of Urology, vol. 149, Jun. 1993, pp. 1613-1616.Applicant
Parkins, “Brain cooling in the Prevention of brain Damage During Periods of Circulatory Occlusion in Dogs,” Annals of Surgery, vol. 140, No. 3, Apr. 1954, pp. 284-289.Applicant
Piepgras, “Rapid Active Internal Core Cooling for Induction of Moderate Hypothermia in Head Injury by Use of an Extracorporeal Heat Exchanger,” Neurosurgery, vol. 42, No. 2, Feb. 1998, pp. 311-318.Applicant
Plattner, Olga, et al., “Efficiacy of Intraoperative Cooling Methods,” Anesthesiology, 87:1089-95, 1997.Applicant
Pond, Harry S. et al., “The Effect of Moderate Hypothermia on Canine Bladder”. Investigative Urology, vol. 7, No. 6, May 1970, pp 460-466.Applicant
Rijken, “Plasminogen Activation at Low Temperatures in Plasma Samples Containing Therapeutic Concentrations of Tissue-Type Plasminogen Activator of Other Thrombolytic Agents,” Place of Publication Unknown, Oct. 1989, pp. 47-52.Applicant
Roehrorn, Claus G., et al., “Temperature Mapping in the Canine Prostate During Transurethrally-Applied Local Microwave Hyperthermia,” The Prostate, vol. 20, 1992, pp. 97-104.Applicant
Schwartz, “Cerebral Blood Flow During Low-Flow Hypothermic Cardiopulmonary Bypass in Baboons,” Anesthesiology, vol. 81, No. 4, Jun. 1994, pp. 959-964.Applicant
Schwartz, “Selective Cerebral Hypothermia by Means of Transfemoral Intenral Carotid Artery Catheterization,” Radiology, vol. 201, No. 2, May 1996, pp. 571-572.Applicant
Schwartz, A.E. et al., “Isolated cerebral hypothermia by single carotid artery perfusion of extracorporeally cooled blood in baboons,” Neurosurgery 39(3): 577-582.Applicant
Sessler, “Temperature-Monitoring and Thermal Management Guidelines,” Anesthesiology 1998; 89:1298-1300.Applicant
Shiraki, K. et al., “Esophageal and Tympanic Temperature Responses to Core Blood Temperature Changes During Hyperthermia,” The American Physiological Society, 1986, pp. 98-102.Applicant
Steen, “The Detrimental Effects of Prolonged Hypothermia and Rewarming in the Dog,” Anesthesiology, vol. 52, No.3, Aug. 1979. pp. 224-230.Applicant
Vandam, “Hypothermia”, The New England Journal of Medicine, Sep. 1959, pp. 546-553.Applicant
White, “Cerebral Hypothermia and Circulatory Arrest,” Mayo Clinic Proceedings, vol. 53, Jul. 1978, pp. 450-458.Applicant
Yenari, “Thrombolysis with Tissue Plasminogen Activator (TPA) is Temperature Dependent,” Thrombosis Research, vol. 77, No. 5, Jul. 1994, pp. 475-481.Applicant
Yoshihara, “Changes in Coagulation and Fibrinolysis Occurring in Dogs During Hypothermia,” Thrombosis Research, vol. 37, No. 4, Aug. 1984, pp. 503-512.Applicant
Zarins, “Circulation in Profound Hypothermia,” Journal of Surgical Research, vol. 14, No. 2, Nov. 1972, pp. 97-104.Applicant